¼¼°èÀÇ ¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§ ½ÃÀå
Autoradiography Films
»óǰÄÚµå : 1731940
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 369 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,026,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,080,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§ ½ÃÀåÀº 2030³â±îÁö 1¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 1¾ï 3,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§ ½ÃÀåÀº 2030³â¿¡´Â 1¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 2.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®µÇ°í ÀÖ´Â ºÎ¹®ÀÇ ÇϳªÀÎ ÇÙÀ¯Á¦ Çʸ§Àº CAGR 2.9%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 9,330¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. X¼± Çʸ§ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 1.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3,540¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 4.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§ ½ÃÀåÀº 2024³â¿¡ 3,540¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 2,860¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 4.6%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.0%¿Í 2.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÚµ¿ ¹æ»ç¼± ÃÔ¿µ Çʸ§ÀÌ ¹æ»ç¼º Ç¥Áö ¿¬±¸ ¹× ºÐÀÚ À̹Ì¡ ¿ëµµ¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§Àº »ý¸í°úÇÐ, Á¦¾à ¿¬±¸°³¹ß, ¹ÙÀÌ¿À¸ÞµðÄà ¿¬±¸ µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ¹æ»ç¼º Ç¥Áö È­ÇÕ¹°ÀÇ °ËÃâ ¹× ºÐ¼®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ Çʸ§Àº ÇҷΰÕÈ­Àº ¿¡¸ÖÀüÀ¸·Î Ư¼ö ÄÚÆÃµÇ¾î 14C, 3H, 35S, 32P¿Í °°Àº ¹æ»ç¼ºµ¿À§¿ø¼Ò¿¡¼­ ¹æÃâµÇ´Â ÀÌ¿ÂÈ­ ¹æ»ç¼±¿¡ ¹ÝÀÀÇÏ¿© °Ö, ºí·Ô, Á¶Á÷ ÀýÆí »óÀÇ ºÐÀÚ ºÐÆ÷¸¦ °íÇØ»óµµ·Î À̹ÌÁöÈ­ÇÕ´Ï´Ù. µðÁöÅÐ ÀÚµ¿ ¹æ»ç¼± ÃÔ¿µ ¹× Çü±¤Ã¼ À̹Ì¡ ±â¼úÀÇ ºÎ»ó¿¡µµ ºÒ±¸Çϰí ÀÚµ¿ ¹æ»ç¼± ÃÔ¿µ Çʸ§Àº Ź¿ùÇÑ °ø°£ ÇØ»óµµ, »ç¿ë ÆíÀǼº, ¹æ»ç¼± È­ÇÐ ¹× Àü±â¿µµ¿ ºÐ¼®ÀÇ ±âÁ¸ ¿öÅ©Ç÷οì¿ÍÀÇ È£È¯¼ºÀ¸·Î ÀÎÇØ ¿©ÀüÈ÷ ³Î¸® ¼±È£µÇ°í ÀÖ½À´Ï´Ù.

¿¬±¸ÀÚµéÀº DNA/RNA È¥¼ºÈ­, ´Ü¹éÁú ±¹¼ÒÈ­, ´ë»ç Ȱ¼º, ¾à¹° °áÇÕÀÇ ÀÚµ¿ ¹æ»ç¼ºµ¿À§¿ø¼Ò ½Ã°¢È­¿¡¼­ ÀÌ Çʸ§À» ½Å·ÚÇϰí ÀÖ½À´Ï´Ù. °í°¨µµ, ³ÐÀº µ¿Àû ¹üÀ§, ¹°¸®Àû À̹ÌÁö ÀúÀå ´É·ÂÀ¸·Î ÀÎÇØ Çмú, Á¦¾à ¹× Á¤ºÎ ¿¬±¸¼Ò¿¡¼­ ƯÈ÷ À¯¿ëÇÏ°Ô »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÌ ÀüÀÓ»ó½ÃÇè ¹× ¹æ»ç¼º ¸®°£µå °áÇÕ ºÐ¼®¿¡¼­ ½Å·ÚÇÒ ¼ö ÀÖ°í ÃßÀû °¡´ÉÇÑ µ¥ÀÌÅ͸¦ Áö¼ÓÀûÀ¸·Î ¿ä±¸Çϰí ÀÖ´Â °¡¿îµ¥, ¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§Àº ¹æ»ç¼ºµ¿À§¿ø¼Ò¸¦ ÀÌ¿ëÇÑ ½ÇÇè¿¡¼­ ºñ¿ë È¿À²ÀûÀ̰í, ÀÔÁõµÈ, À¯Áöº¸¼ö°¡ ÀûÀº Á¤¼º ¹× ¹ÝÁ¤·® ºÐ¼® ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù.

Çʸ§ ÄÚÆÃ, ¿¡¸ÖÀü ±â¼ú, ¿öÅ©Ç÷οì ȣȯ¼ºÀº ½ÇÇè½Ç¿¡¼­ Áö¼ÓÀûÀÎ »ç¿ëÀ» ¾î¶»°Ô Áö¿øÇϴ°¡?

ÇҷΰÕÈ­Àº ¿¡¸ÖÀüÀÇ ¹èÇÕ, Çʸ§ ±âÆÇÀÇ ¿£Áö´Ï¾î¸µ, ÄÚÆÃÀÇ ±ÕÀϼº µîÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ÀÚµ¿ ¹æ»ç¼± ÃÔ¿µ Çʸ§ÀÇ ¼º´É Ư¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ÃֽŠÇʸ§Àº ´õ ¹Ì¼¼ÇÑ ÀÔÀÚ ±¸Á¶¿Í °³¼±µÈ ÄÜÆ®¶ó½ºÆ® ±×¶óµ¥À̼ÇÀ» Á¦°øÇϰí, Àú°­µµ ¹ß±¤À» ´õ ¼±¸íÇÏ°Ô °¡½ÃÈ­Çϸç, ºÐÀÚ ¹êµå¿Í Á¶Á÷ µðÅ×ÀÏÀ» ´õ ¼±¸íÇÏ°Ô ºÐÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÈƼÇÒ·¹ÀÌ¼Ç ÄÚÆÃ, À¯¿¬ÇÑ ±âÆÇ, ¿¡¸ÖÀüÀÇ µÎ²² Á¦¾î¸¦ ÅëÇØ ¾ÈÁ¤ÀûÀÎ ½ÅÈ£ Æ÷Âø°ú ¹è°æ ÀâÀ½À» ÃÖ¼ÒÈ­ÇÏ¿© Àå½Ã°£ ³ëÃâ À̹Ì¡¿¡¼­ ½Å·ÚÇÒ ¼ö ÀÖ´Â µ¥ÀÌÅÍ Æ÷ÂøÀ» Áö¿øÇÕ´Ï´Ù.

¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§Àº ±âÁ¸ÀÇ ¾Ï½Ç ¿öÅ©Ç÷ο쿡 ¿øÈ°ÇÏ°Ô ÅëÇյǵµ·Ï ¼³°èµÇ¾úÀ¸¸ç, ´Ù¾çÇÑ Çʸ§ Ä«¼¼Æ®, °¨±¤ ½ºÅ©¸°, Çö»ó¾×°ú ȣȯµË´Ï´Ù. Àü¿ë ¼ÒÇÁÆ®¿þ¾î³ª ÀüÀÚ ÀÎÇÁ¶ó°¡ ÇÊ¿äÇÏÁö ¾Ê±â ¶§¹®¿¡ ÀÚ¿øÀÌ Á¦ÇÑÀûÀ̰ųª ºÐ»êµÈ ½ÇÇè½Ç¿¡¼­ Áß¿äÇÑ ÀÌÁ¡ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ·¹°Å½Ã ½Ã½ºÅÛÀ̳ª ¹æ»ç¼º Ç¥Áö °ËÃâÀ» Áß½ÉÀ¸·Î ±¸ÃàµÈ Ç¥ÁØ ÇÁ·ÎÅäÄÝÀ» °¡Áø ¿¬±¸¼ÒÀÇ °æ¿ì, ¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§Àº Àå±âÀûÀÎ ¿î¿µ ¾ÈÁ¤¼º°ú ÀçÇö¼ºÀ» Áö¼ÓÀûÀ¸·Î Á¦°øÇÏ´Â ÇÑÆí, º¸Á¸ ±â°£À» ¿¬ÀåÇÏ°í °³¹ß ½Ã°£À» ´ÜÃàÇÏ´Â »õ·Î¿î Á¦ÇüÀº À̹Ì¡ ÇÁ·Î¼¼½º¸¦ ´õ¿í °£¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÚµ¿¹æ»ç¼± ÃÔ¿µ Çʸ§ ¼ö¿ä´Â ¾îµð°¡ °­Çϰí, ¾î¶² ¿ëµµ°¡ »ç¿ëÀ» ÃËÁøÇϴ°¡?

µðÁöÅÐ À̹Ì¡ ±â¼úÀÌ ºÎ»óÇÏ´Â °¡¿îµ¥, ¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§¿¡ ´ëÇÑ ¼ö¿ä´Â Çмú¿¬±¸ ±â°ü, Á¦¾à °³¹ß ¿¬±¸¼Ò, ÇÙÀÇÇÐ ¿¬±¸¼¾ÅÍ, ³ó¾à ½ÃÇè ½Ã¼³ µî¿¡¼­ °ß°íÇÑ ¼ö¿ä¸¦ À¯ÁöÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç µî ±âÃÊ ¿¬±¸ Ȱµ¿ÀÌ È°¹ßÇÑ Áö¿ª¿¡¼­´Â ¹æ»ç¼º ÃßÀûÀÚ ¿¬±¸¸¦ À§ÇÑ ¿ÀÅä¶óµð¿À±×·¡ÇÇÀÇ È®¸³µÈ ¿öÅ©Ç÷ο찡 À¯ÁöµÇ°í ÀÖ½À´Ï´Ù. ÀÌµé ½ÃÀå¿¡¼­´Â ºÐÀÚ»ý¹°ÇÐ, ½Å°æ°úÇÐ, Á¾¾çÇÐ, ¾àµ¿ÇÐ ¿¬±¸¸¦ À§ÇØ ¿ÀÅä¶óµð¿À±×·¡Çǰ¡ °Ö Àü±â¿µµ¿, ºí·ÔÆÃ ºÐ¼®, in vivo À̹Ì¡°ú ÇÔ²² »ç¿ëµÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù.

ÁÖ¿ä ¿ëµµ·Î´Â À¯ÀüÀÚ ¹ßÇö ¿¬±¸, ¹æ»ç¼º ¸®°£µå °áÇÕ ºÐ¼®, ´ë»ç °æ·Î ÃßÀû, ¹æ»ç¼º ÇÁ·Îºê °ËÃâ µîÀÌ ÀÖ½À´Ï´Ù. Á¦¾à ±â¾÷¿¡¼­´Â ¹æ»ç¼º Ç¥Áö ¹°ÁúÀÇ Á¶Á÷³» Á¤È®ÇÑ ÃßÀûÀÌ ÇʼöÀûÀÎ ÀǾàǰ Èĺ¸¹°ÁúÀÇ ADME(Èí¼ö, ºÐÆ÷, ´ë»ç, ¹è¼³) ÇÁ·ÎÆÄÀϸµ¿¡ ¿ÀÅä¶óµð¿À±×·¡ÇǸ¦ ÀÚÁÖ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. µ¶¼ºÇÐ ¹× µ¿À§¿ø¼Ò ±â¹Ý ³ó¾÷ ¿¬±¸¿¡¼­ ÀÚµ¿¹æ»ç¼± ÃÔ¿µ Çʸ§Àº ³ó¾àÀÇ ºÐÆ÷¿Í ¼¼Æ÷ ¼öÁØ¿¡¼­ »ýÈ­ÇÐÀû ¿µÇâÀ» ¸ð´ÏÅ͸µÇϱâ À§ÇØ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹Ýº¹ÀûÀÎ ÀÌ¿ë »ç·Ê´Â ƯÈ÷ ¹æ»ç¼º ¹°Áú ºÐÆ÷ÀÇ °íÇØ»óµµ À̹Ì¡ÀÌ ÇÊ¿äÇÑ °æ¿ì ÀÌ ¸ÅüÀÇ Áö¼ÓÀûÀÎ °ü·Ã¼ºÀ» º¸ÀåÇÕ´Ï´Ù.

ÀÚµ¿ ¹æ»ç¼± ÃÔ¿µ Çʸ§ÀÇ Áö¼ÓÀûÀÎ °ü·Ã¼º°ú Àü ¼¼°è »ç¿ëÀÇ ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§ÀÇ Áö¼ÓÀûÀÎ »ç¿ëÀº ·¹°Å½Ã ½Ã½ºÅÛ°úÀÇ È£È¯¼º, Ź¿ùÇÑ °ø°£ ÇØ»óµµ, ºÐÀÚ °úÇп¡¼­ ¹æ»ç¼ºµ¿À§¿ø¼Ò ±â¹Ý ½ÇÇè ±â¼úÀÇ Áö¼ÓÀûÀÎ À¯¿ë¼ºÀÇ Á¶ÇÕ¿¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¸¹Àº ½ÇÇè½Ç¿¡¼­ Çʸ§ ±â¹Ý ÀÚµ¿¹æ»ç¼±ÃÔ¿µÀ» Áß½ÉÀ¸·Î È¿°úÀûÀÎ ÇÁ·ÎÅäÄÝ, ÀÎÇÁ¶ó ¹× ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ±¸ÃàµÇ¾î ÀÖÀ¸¹Ç·Î ´Ü±âÀûÀ¸·Î µðÁöÅÐ ´ëüǰÀ¸·Î ÀüȯÇÏ´Â °ÍÀº ºñ¿ëÀÌ ¸¹ÀÌ µé°Å³ª Çö½ÇÀûÀÌÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù. ¼³Á¤ÀÇ ¿ëÀ̼º, ÃÖ¼ÒÇÑÀÇ ¼ÒÇÁÆ®¿þ¾î ¹× ͏®ºê·¹À̼ÇÀÇ Çʿ伺, ´«¿¡ º¸ÀÌ´Â ¾ÆÄ«ÀÌºê ±â·ÏÀ» »ý¼ºÇÒ ¼ö ÀÖ´Ù´Â Á¡µµ ±ÔÁ¦ ¹× ÇмúÀû ȯ°æ¿¡¼­ Çʸ§À» ¼±È£ÇÏ´Â ¿äÀÎÀÔ´Ï´Ù.

°ø±Þ¾÷üµéÀº Çʸ§ Á¦Çü °³¼±, ȣȯ °¡´ÉÇÑ ´Ù¾çÇÑ Çö»ó¾× °ø±Þ, ¹æ»ç¼± ¿µ»ó ¿¬±¸¼Ò¸¦ À§ÇÑ ¸ÂÃãÇü Áö¿ø¿¡ Áö¼ÓÀûÀ¸·Î ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ À̹Ì¡ ½Ã½ºÅÛÀÇ º¸±ÞÀÌ È®´ëµÇ°í ÀÖÁö¸¸, ÀÚµ¿ ¹æ»ç¼± ÃÔ¿µ Çʸ§Àº ¿©ÀüÈ÷ ÇØ»óµµ, ÆíÀǼº, ·¹°Å½Ã ¿öÅ©Ç÷οìÀÇ ¹«°á¼ºÀ» ¿ì¼±½ÃÇÏ´Â ½Ã³ª¸®¿À¿¡¼­ ¿©ÀüÈ÷ ¼±ÅõǴ ¹æ½ÄÀÔ´Ï´Ù. ¹æ»ç¼º Ç¥Áö ºÐ¼®Àº ±âÃÊ ¹× Áß°³ ¿¬±¸¿¡¼­ ¿©ÀüÈ÷ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿ÀÅä¶óµð¿À±×·¡ÇÇ Çʸ§ÀÌ ºü¸£°Ô µðÁöÅÐÈ­µÇ´Â »ý¸í°úÇÐ »ê¾÷¿¡¼­ °íÁ¤¹Ð ¾Æ³¯·Î±× ºÐÀÚ À̹Ì¡ Ç÷§ÆûÀ¸·Î¼­ Æ´»õ ½ÃÀåÀ» °è¼Ó À¯ÁöÇÒ ¼ö Àִ°¡?

ºÎ¹®

Á¦Ç°(ÇÙÀ¯Á¦, X¼± Çʸ§, ±âŸ Á¦Ç°), ¿ëµµ(ºí·ÎÆÃ, ½ÃÄö½Ì, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, º´¿ø¡¤Å¬¸®´Ð, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 36°Ç)

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ÀÎÀ§ÀûÀÎ ¼öÀÔ¿ø°¡ Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Global Industry Analysts´Â ¼¼°è ÁÖ¿ä ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®(1,4,949¸í), ½ÌÅ©ÅÊÅ©(62°³ ±â°ü), ¹«¿ª ¹× »ê¾÷ ´Üü(171°³ ±â°ü)ÀÇ Àü¹®°¡µéÀÇ ÀǰßÀ» ¸é¹ÐÈ÷ °ËÅäÇÏ¿© »ýŰ迡 ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ°í »õ·Î¿î ½ÃÀå Çö½Ç¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¸ðµç ÁÖ¿ä ±¹°¡ÀÇ Àü¹®°¡¿Í °æÁ¦ÇÐÀÚµéÀÌ °ü¼¼¿Í ±×°ÍÀÌ ÀÚ±¹¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀǰßÀ» ÃßÀû Á¶»çÇß½À´Ï´Ù.

Global Industry Analysts´Â ÀÌ·¯ÇÑ È¥¶õÀÌ ÇâÈÄ 2-3°³¿ù ³»¿¡ ¸¶¹«¸®µÇ°í »õ·Î¿î ¼¼°è Áú¼­°¡ º¸´Ù ¸íÈ®ÇÏ°Ô È®¸³µÉ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, Global Industry Analysts´Â ÀÌ·¯ÇÑ »óȲÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇϰí ÀÖ½À´Ï´Ù.

2025³â 4¿ù: Çù»ó ´Ü°è

À̹ø 4¿ù º¸°í¼­¿¡¼­´Â °ü¼¼°¡ ¼¼°è ½ÃÀå Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú Áö¿ªº° ½ÃÀå Á¶Á¤¿¡ ´ëÇØ ¼Ò°³ÇÕ´Ï´Ù. ´ç»çÀÇ ¿¹ÃøÀº °ú°Å µ¥ÀÌÅÍ¿Í ÁøÈ­ÇÏ´Â ½ÃÀå ¿µÇâ¿äÀÎÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.

2025³â 7¿ù: ÃÖÁ¾ °ü¼¼ Àç¼³Á¤

°í°´´Ôµé²²´Â °¢ ±¹°¡º° ÃÖÁ¾ ¸®¼ÂÀÌ ¹ßÇ¥µÈ ÈÄ 7¿ù¿¡ ¹«·á ¾÷µ¥ÀÌÆ® ¹öÀüÀ» Á¦°øÇØ µå¸³´Ï´Ù. ÃÖÁ¾ ¾÷µ¥ÀÌÆ® ¹öÀü¿¡´Â ¸íÈ®ÇÏ°Ô Á¤ÀÇµÈ °ü¼¼ ¿µÇ⠺м®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

»óÈ£ ¹× ¾çÀÚ °£ ¹«¿ª°ú °ü¼¼ÀÇ ¿µÇ⠺м® :

¹Ì±¹ <>Áß±¹ <>¸ß½ÃÄÚ <>ij³ª´Ù <>EU <>ÀϺ» <>Àεµ <>±âŸ 176°³±¹

¾÷°è ÃÖ°íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®: Global Industry AnalystsÀÇ Áö½Ä ±â¹ÝÀº ±¹°¡, ½ÌÅ©ÅÊÅ©, ¹«¿ª ¹× »ê¾÷ ´Üü, ´ë±â¾÷, ±×¸®°í ¼¼°è °è·® °æÁ¦ »óȲÀÇ Àü·Ê ¾ø´Â ÆÐ·¯´ÙÀÓ ÀüȯÀÇ ¿µÇâÀ» °øÀ¯ÇÏ´Â ºÐ¾ßº° Àü¹®°¡ µî °¡Àå ¿µÇâ·Â ÀÖ´Â ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ Æ÷ÇÔÇÑ 14,949¸íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ ÃßÀûÇϰí ÀÖ½À´Ï´Ù. 16,491°³ ÀÌ»óÀÇ º¸°í¼­ ´ëºÎºÐ¿¡ ¸¶ÀϽºÅæ¿¡ ±â¹ÝÇÑ 2´Ü°è Ãâ½Ã ÀÏÁ¤ÀÌ Àû¿ëµÇ¾î ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Autoradiography Films Market to Reach US$150.0 Million by 2030

The global market for Autoradiography Films estimated at US$130.0 Million in the year 2024, is expected to reach US$150.0 Million by 2030, growing at a CAGR of 2.4% over the analysis period 2024-2030. Nuclear Emulsion Films, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$93.3 Million by the end of the analysis period. Growth in the X-Ray Film segment is estimated at 1.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$35.4 Million While China is Forecast to Grow at 4.6% CAGR

The Autoradiography Films market in the U.S. is estimated at US$35.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$28.6 Million by the year 2030 trailing a CAGR of 4.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Global Autoradiography Films Market - Key Trends & Drivers Summarized

Why Are Autoradiography Films Remaining Indispensable in Radiolabeled Research and Molecular Imaging Applications?

Autoradiography films continue to play a vital role in detecting and analyzing radiolabeled compounds across a broad spectrum of life sciences, pharmaceutical R&D, and biomedical research applications. These films are specially coated with silver halide emulsions that react to ionizing radiation emitted by radioisotopes such as ^14C, ^3H, ^35S, and ^32P-producing high-resolution images of molecular distribution on gels, blots, or tissue sections. Despite the rise of digital autoradiography and phosphor imaging technologies, autoradiography films remain widely preferred for their unmatched spatial resolution, ease of use, and compatibility with existing workflows in radiochemical and electrophoretic assays.

Researchers rely on these films for visualizing DNA/RNA hybridizations, protein localization, metabolic activity, and drug-binding studies in autoradiographic formats. Their high sensitivity, broad dynamic range, and ability to archive physical images make them especially valuable in academic, pharmaceutical, and government laboratories. As regulatory agencies continue to demand robust and traceable data in preclinical studies and radioligand binding assays, autoradiography films offer a cost-effective, proven, and low-maintenance method for qualitative and semi-quantitative analysis in radioisotope-based experimentation.

How Are Film Coatings, Emulsion Technologies, and Workflow Compatibility Supporting Sustained Use in Research Labs?

Advancements in silver halide emulsion formulation, film substrate engineering, and coating uniformity are enhancing the performance characteristics of autoradiography films. Modern films offer finer grain structures and improved contrast gradients, enabling clearer visualization of low-intensity emissions and sharper resolution of molecular bands or tissue details. Anti-halation coatings, flexible base materials, and controlled emulsion thickness ensure consistent signal capture and minimized background noise-supporting reliable data capture in long-exposure imaging.

Autoradiography films are also engineered for seamless integration into traditional darkroom workflows, with compatibility across a wide range of film cassettes, intensifying screens, and chemical developers. Their use requires no proprietary software or electronic infrastructure, which is a key advantage in resource-limited or decentralized laboratories. For institutions with legacy systems or standard protocols built around radiolabeled detection, autoradiography films continue to offer long-term operational stability and reproducibility, while newer formulations with extended shelf life and faster development times further streamline the imaging process.

Where Is Demand for Autoradiography Films Holding Strong and Which Applications Are Driving Usage?

While digital imaging technologies are gaining ground, demand for autoradiography films remains steady across academic research institutions, pharmaceutical development labs, nuclear medicine research centers, and agrochemical testing facilities. Regions with strong foundational research activity-such as North America, Europe, and parts of Asia-Pacific-continue to maintain established autoradiography workflows for radioactive tracer studies. In these markets, autoradiography is often used in conjunction with gel electrophoresis, blotting assays, and in vivo imaging for molecular biology, neuroscience, oncology, and pharmacokinetics research.

Key application areas include gene expression studies, radioligand binding analysis, metabolic pathway tracing, and radioactive probe detection. Pharmaceutical companies frequently use autoradiography in ADME (absorption, distribution, metabolism, and excretion) profiling of drug candidates, where precision tracking of radiolabeled substances in tissues is essential. In toxicology and isotope-based agricultural studies, autoradiography films are applied to monitor pesticide distribution or biochemical effects at the cellular level. These recurring use cases ensure continued relevance of the medium, especially where high-resolution imaging of radioactive distribution is required.

What Is Fueling the Continued Relevance and Global Use of Autoradiography Films?

The sustained use of autoradiography films is driven by a combination of legacy system compatibility, unmatched spatial resolution, and the enduring utility of radioisotope-based experimental techniques in molecular sciences. Many laboratories have validated protocols, infrastructure, and regulatory frameworks built around film-based autoradiography, making transitions to digital alternatives costly or impractical in the short term. The simplicity of setup, minimal need for software or calibration, and ability to produce tangible archival records are additional factors supporting film preference in regulatory or academic settings.

Suppliers are continuing to invest in improved film formulations, broader availability of compatible development chemicals, and targeted support for radiological imaging labs. While digital imaging systems are expanding their footprint, autoradiography films remain the modality of choice in scenarios that prioritize resolution, simplicity, and legacy workflow alignment. As radiolabeled assays retain their importance in fundamental and translational research, a key consideration persists: Can autoradiography films continue to maintain their niche as the go-to platform for high-precision, analog molecular imaging amidst a rapidly digitizing life sciences landscape?

SCOPE OF STUDY:

The report analyzes the Autoradiography Films market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Nuclear Emulsion, X-Ray Film, Other Products); Application (Blotting, Sequencing, Other Applications); End-Use (Pharma & Biotech Companies, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â